Borgiani L, Cogorno P, Buccaran G, Gallo L, Rovida S, Canepa M
Servizio di Anatomia Patologica, E.O. Ospedali Galliera.
Pathologica. 1994 Aug;86(4):350-5.
We evaluated breast cancer specimens from 150 patients after a follow-up more than 10 years, by means of DNA flow cytometry, immunohistochemistry (cerbB2 and Cathepsin D) and argyrophilic (AgNORs) methods. In univariate analysis all indexes studied provide prognostic information about the disease free survival, whereas in the multivariate Cox model the DNA Index is the most important prognostic factor. We conclude that the data obtained from DNA flow cytometry, associated with other parameters, can be of greatest importance for the decision an the level of aggressiveness of adjuvant therapy for the decision an the level of aggressiveness of adjuvant therapy for a individual patients.
我们通过DNA流式细胞术、免疫组织化学(cerbB2和组织蛋白酶D)和嗜银染色(AgNORs)方法,对150例患者超过10年随访后的乳腺癌标本进行了评估。单因素分析中,所有研究指标均提供了无病生存的预后信息,而在多变量Cox模型中,DNA指数是最重要的预后因素。我们得出结论,从DNA流式细胞术获得的数据,结合其他参数,对于确定个体患者辅助治疗的侵袭性水平可能至关重要。